Eribulin Mesylate
NDC 10019-080, Eribulin Mesylate, injection, from Baxter Healthcare Company.
- Product NDC
- 10019-080
- Status
- Listed
- Labeler
- Baxter Healthcare Company
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217250
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10019-080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERIBULIN MESYLATE.5 mg/mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10019-080-01 | 10019008001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/62690292-b1de-46f1-b6e8-012a725f8c63Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=10019-080
Use it
Look up 10019-080 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10019-080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10019-080. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.